Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation.
RORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis.
Developing a therapeutic plan for treating MS: evidence for new treatments.
Models for treating depression in specialty medical settings: a narrative review.
FTY720 protects neuronal cells from damage induced by human prion protein by inactivating the JNK pathway.
Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies.
Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
The elusive biomarker for personalized medicine in multiple sclerosis: The search continues.
Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis.
The Management of Pediatric Multiple Sclerosis.
Corrigendum.
Current status of myelin replacement therapies in multiple sclerosis.
18F-FDG PET/CT in Tumefactive Multiple Sclerosis.
Unmet education, psychological and peer support needs of people with multiple sclerosis.
Distinguishing Susac's syndrome from multiple sclerosis.
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Acute Lymphoblastic Leukemia in a Man Treated With Fingolimod for Relapsing Multiple Sclerosis.
Purification of Mouse Brain Vessels.
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis.
OLFACTORY ENSHEATHING GLIA CELL THERAPY AND TUBULAR CONDUIT ENHANCE NERVE REGENERATION AFTER MOUSE SCIATIC NERVE TRANSECTION.
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy.
Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials.
HMGB1 in Development and Diseases of the Central Nervous System.
Headache and neurological disease in pregnancy.
Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study.

Pages